1.
Clin Res Hepatol Gastroenterol
; 38(4): e69-71, 2014 Sep.
Article
in English
| MEDLINE
| ID: mdl-24461554
Subject(s)
Acute Kidney Injury/chemically induced , Antiviral Agents/adverse effects , Interferon-alpha/adverse effects , Oligopeptides/adverse effects , Polyethylene Glycols/adverse effects , Ribavirin/adverse effects , Antiviral Agents/therapeutic use , Female , Hepatitis C/drug therapy , Humans , Interferon-alpha/therapeutic use , Middle Aged , Oligopeptides/therapeutic use , Polyethylene Glycols/therapeutic use , Recombinant Proteins/adverse effects , Recombinant Proteins/therapeutic use , Ribavirin/therapeutic use , Severity of Illness Index
2.
Transpl Infect Dis
; 14(6): E134-6, 2012 Dec.
Article
in English
| MEDLINE
| ID: mdl-22998023
ABSTRACT
Bordetella holmesii is a gram-negative rod that was initially identified in 1995. It causes bacteremia, pneumonia, and endocarditis mostly in patients with anatomical or functional asplenia. We report here, to the best of our knowledge, the first case of B. holmesii bacteremia in a renal transplant recipient following rituximab therapy for recurrence of membranoproliferative glomerulonephritis.
